Characteristics | TCC ≤ 7 (N = 169) | TCC ≥ 8 (N = 219) | ||||
---|---|---|---|---|---|---|
COD < 460 mg/m2 (N = 73) | COD ≥ 460 mg/m2 (N = 96) | P value | COD < 720 mg/m2 (N = 90) | COD ≥ 720 mg/m2 (N = 129) | P value | |
Age / years old | ||||||
≥ 55 | 44 (60.3%) | 55 (57.3%) | 0.697 | 45 (50.0%) | 51 (39.5%) | 0.125 |
< 55 | 29 (39.7%) | 41 (42.7%) | 45 (50.0%) | 78 (60.5%) | ||
Gender | ||||||
Male | 46 (63.0%) | 71 (74.0%) | 0.127 | 63 (70.0%) | 78 (60.5%) | 0.147 |
Female | 27 (37.0%) | 25 (26.0%) | 27 (30.0%) | 51 (39.5%) | ||
Anemia | ||||||
Yes | 26 (35.6%) | 27 (28.1%) | 0.298 | 33 (36.7%) | 35 (27.1%) | 0.134 |
No | 47 (64.4%) | 69 (71.9%) | 57 (63.3%) | 94 (72.9%) | ||
Differentiation | ||||||
Poor | 11 (16.7%) | 12 (12.9%) | 0.506 | 8 (8.9%) | 20 (15.5%) | 0.149 |
Moderate-good | 62 (83.3%) | 84 (87.1%) | 82 (91.1%) | 109 (84.5%) | ||
CEA / ng/ml | ||||||
≥ 5 | 36 (49.3%) | 39 (46.0%) | 0.260 | 42 (46.7%) | 56 (43.4%) | 0.634 |
< 5 | 37 (50.7%) | 57 (54.0%) | 48 (53.3%) | 73 (56.6%) | ||
CA19–9 / U/ml | ||||||
≥ 35 | 18 (24.7%) | 15 (15.6%) | 0.581 | 11 (12.2%) | 23 (17.8%) | 0.260 |
< 35 | 55 (75.3%) | 81 (84.4%) | 79 (87.8%) | 106 (82.2%) | ||
Clinical stage | ||||||
cIII | 47 (64.4%) | 73 (76.0%) | 0.098 | 71 (78.9%) | 112 (86.8%) | 0.119 |
cII | 26 (35.6%) | 23 (24.0%) | 19 (21.1%) | 17 (13.2%) |